The influence of atypical antipsychotic drugs on sexual function

References

• GroverSGhoshASarkarSChakrabartiSAvasthiASexual dysfunction in clinically stable patients with bipolar disorder receiving lithiumJ Clin Psychopharmacol201434447548224781439
   PubMed Web of Science ®Google Scholar
• HamiltonLDMestonCMChronic stress and sexual function in womenJ Sex Med201310102443245423841462
   PubMed Web of Science ®Google Scholar
• AgmoAOn the intricate relationship between sexual motivation and arousalHorm Behav201159568168820816969
   PubMed Web of Science ®Google Scholar
• BoinACNozoeKTPoleselDNAndersenMLTufikSThe potential role of sleep in sexual dysfunction in patients with schizophreniaSchizophr Res20141541–312612724556470
   PubMed Web of Science ®Google Scholar
• KopecekMBaresMSvarcJDockeryCHoracekJHyperprolactinemia after low dose of amisulprideNeuro Endocrinol Lett200425641942215665803
   PubMed Web of Science ®Google Scholar
• OglodekESzotaAAraszkiewiczAElectroconvulsive therapy in a patient with drug-resistant depression and thyroid hormone imbalanceAust N Z J Psychiatry2014481969723814070
   PubMed Web of Science ®Google Scholar
• OglodekEWiczkowskiASieronABilska-UrbanAMośDThe effect of extremely low-frequency magnetic fields on the morphology of thyroid gland cells in female ratsPol J Environ Stud2008175757763
   Web of Science ®Google Scholar
• KristensenDHagemanIBauerJJørgensenMBCorrellCUAntipsychotic polypharmacy in a treatment-refractory schizophrenia population receiving adjunctive treatment with electroconvulsive therapyJ ECT201329427127623859980
   PubMed Web of Science ®Google Scholar
• MillierAAmriIBoyerLAuquierPToumiMUtility decrements associated with side effects in schizophreniaJ Med Econ2014171285386125211094
   PubMedGoogle Scholar
• ConnollyATaylorDFactors associated with non evidence-based prescribing of antipsychoticsTher Adv Psychopharmacol20144624725625489476
   PubMedGoogle Scholar
• OglodekESzotaAAraszkiewiczAOlanzapine-induced neuroleptic malignant syndrome after 10 years of treatmentAust N Z J Psychiatry2013471097223630396
   PubMed Web of Science ®Google Scholar
• SzotaAOgłodekEAraszkiewiczAFever development in neuroleptic malignant syndrome during treatment with olanzapine and clozapinePharmacol Rep201365227928723744413
   PubMed Web of Science ®Google Scholar
• GrundmannMKacirovaIUrinovskaRTherapeutic drug monitoring of atypical antipsychotic drugsActa Pharm201464438740125531781
   PubMed Web of Science ®Google Scholar
• SzotaAOglodekEAraszkiewiczAA female patient with depression and conversion disorder following brain tumor surgeryAust N Z J Psychiatry201347121213121423975697
   PubMed Web of Science ®Google Scholar
• SzotaAOgłodekEAraszkiewiczABipolar disorder: mixed episodes concomitant with gambling addictionAust N Z J Psychiatry201348658658724366857
   PubMed Web of Science ®Google Scholar
• GründerGWetzelHSchlösserRNeuroendocrine response to antipsychotics: effects of drug type and genderBiol Psychiatry199945189979894580
   PubMed Web of Science ®Google Scholar
• BevanJSInterpreting prolactin levels: implications for the management of large pituitary lesionsBr J Neurosurg199151362021431
   PubMedGoogle Scholar
• FreemanMEKanyicskaBLerantANagyGProlactin: structure, function, and regulation of secretionPhysiol Rev20008041523163111015620
   PubMed Web of Science ®Google Scholar
• HaddadPMWieckAAntipsychotic-induced hyperprolactinaemia: mechanisms, clinical features and managementDrugs200464202291231415456328
   PubMed Web of Science ®Google Scholar
• KinonBJGilmoreJALiuHHalbreichUMPrevalence of hyperprolactinemia in schizophrenic patients treated with conventional antipsychotic medications or risperidonePsychoneuroendocrinology200328suppl 2556812650681
   PubMed Web of Science ®Google Scholar
• PeuskensJPaniLDetrauxJDe HertMThe effects of novel and newly approved antipsychotics on serum prolactin levels: a comprehensive reviewCNS Drugs201428542145324677189
   PubMed Web of Science ®Google Scholar
• WeizmannAWeizmannRHartJMaozBWijsenbeekHBen DavidMThe correlation of increased serum prolactin levels with decreased sexual desire and activity in elderly menJ Am Geriatr Soc19833184854886875154
   PubMed Web of Science ®Google Scholar
• AsmalLFlegarSJWangJRummel-KlugeCKomossaKLeuchtSQuetiapine versus other atypical antipsychotics for schizophreniaCochrane Database Syst Rev201311CD00662524249315
   PubMed Web of Science ®Google Scholar
• SuzukiYSugaiTFukuiNDifferences in plasma prolactin levels in patients with schizophrenia treated on monotherapy with five second-generation antipsychoticsSchizophr Res20131451–311611923375624
   PubMed Web of Science ®Google Scholar
• JeongHGLeeMSLeeHYKoYHHanCJoeSHChanges in sexual function and gonadal axis hormones after switching to aripiprazole in male schizophrenia patients: a prospective pilot studyInt Clin Psychopharmacol201227417718322407277
   PubMed Web of Science ®Google Scholar
• BuckleyPFGoldsteinJMEmsleyRAEfficacy and tolerability of quetiapine in poorly responsive, chronic schizophreniaSchizophr Res2004662–314315015061246
   PubMed Web of Science ®Google Scholar
• JummaniRCoffeyBJHyperprolactinemia in an adolescent with psychotic disorder on risperidoneJ Child Adolesc Psychopharmacol200919679179420035598
   PubMed Web of Science ®Google Scholar
• SerrettiAChiesaAA meta-analysis of sexual dysfunction in psychiatric patients taking antipsychoticsInt Clin Psychopharmacol201126313014021191308
   PubMedGoogle Scholar
• DavidSRTaylorCCKinonBJBreierAThe effects of olanzapine, risperidone, and haloperidol on plasma prolactin levels in patients with schizophreniaClin Ther20002291085109611048906
   PubMed Web of Science ®Google Scholar
• KonarzewskaBWołczyńskiSSzulcAGalińskaBPopławskaRWaszkiewiczNEffect of risperidone and olanzapine on reproductive hormones, psychopathology and sexual functioning in male patients with schizophreniaPsychoneuroendocrinology200934112913918838228
   PubMed Web of Science ®Google Scholar
• KimKSPaeCUChaeJHEffects of olanzapine on prolactin levels of female patients with schizophrenia treated with risperidoneJ Clin Psychiatry200263540841312019665
   PubMed Web of Science ®Google Scholar
• BaggaleyMSexual dysfunction in schizophrenia: focus on recent evidenceHum Psychopharmacol200823320120918338766
   PubMed Web of Science ®Google Scholar
• Martin-DuPRBaumannPSexual dysfunctions induced by antidepressants and antipsychoticsRev Med Suisse2008415075876218476641
   PubMedGoogle Scholar
• MuscatelloMRBrunoAPandolfoGMicòUSettineriSZoccaliREmerging treatments in the management of schizophrenia – focus on sertindoleDrug Des Devel Ther20104187201
   PubMed Web of Science ®Google Scholar
• LewisRBagnallALeitnerMSertindole for schizophreniaCochrane Database Syst Rev20002CD00171510796657
   PubMedGoogle Scholar
• JukićMKDrmićSMimicaNEjaculatory dysfunction in patient with schizophrenia on sertindolePsychiatr Danub201022112813120305609
   PubMed Web of Science ®Google Scholar
• CrawfordAMBeasleyCMJrTollefsonGDThe acute and long-term effect of olanzapine compared with placebo and haloperidol on serum prolactin concentrationsSchizophr Res199726141549376336
   PubMed Web of Science ®Google Scholar
• OgłodekEASzotaAJustMJMośDAraszkiewiczAComparison of chemokines (CCL-5 and SDF-1), chemokine receptors (CCR-5 and CXCR-4) and IL-6 levels in patients with different severities of depressionPharmacol Rep201466592092625150002
   PubMed Web of Science ®Google Scholar
• OgłodekEASzotaAMJustMJMośDMAraszkiewiczAThe MCP-1, CCL-5 and SDF-1 chemokines as pro-inflammatory markers in generalized anxiety disorder and personality disordersPharmacol Rep2015671858925560580
   PubMed Web of Science ®Google Scholar
• KleinbergDLDavisJMde CosterRVan BaelenBBrecherMProlactin levels and adverse events in patients treated with risperidoneJ Clin Psychopharmacol199919157619934944
   PubMed Web of Science ®Google Scholar
• BreierAFMalhotraAKSuTPPinalsDAElmanIAdlerCMClozapine and risperidone in chronic schizophrenia: effects on symptoms, parkinsonian side effects, and neuroendocrine responseAm J Psychiatry199915622942989989566
   PubMed Web of Science ®Google Scholar
• Pérez-IglesiasRMataIMartínez-GarcíaOLong-term effect of haloperidol, olanzapine, and risperidone on plasma prolactin levels in patients with first-episode psychosisJ Clin Psychopharmacol201232680480823131886
   PubMed Web of Science ®Google Scholar
• DoufikJOthemanYKhaliliLGhanmiJOuanassAAntipsychotic-induced priapism and management challenges: a case reportEncephale201440651852124709224
   PubMed Web of Science ®Google Scholar
• PenaskovicKMHaqFRazaSPriapism during treatment with olanzapine, quetiapine, and risperidone in a patient with schizophrenia: a case reportPrim Care Companion J Clin Psychiatry2010125PCC.09100939
   Google Scholar
• JagadheesanKThakurAAkhtarSIrreversible priapism during olanzapine and lithium therapyAust N Z J Psychiatry200438538115144518
   PubMed Web of Science ®Google Scholar
• GinoryANguyenMA case of priapism with risperidoneCase Rep Psychiatry2014201424157325379316
   PubMedGoogle Scholar
• CruzadoLVallejosCEPriapism associated with risperidone use: report of one caseRev Med Chil2012140111445144823677191
   PubMed Web of Science ®Google Scholar
• KaramustafaliogluNKaleliogluTTanrioverOGungorFGencAA case report of priapism caused by ziprasidonPsychiatry Investig2003104425427
   Web of Science ®Google Scholar
• KaufmanKRSternLMohebatiAOlsavskyAHwangJZiprasidone-induced priapism requiring surgical treatmentEur Psychiatry2006211485016356688
   PubMed Web of Science ®Google Scholar
• DentonKKolliVSharmaAZiprasidone-induced ischemic priapism requiring surgical intervention: a case reportPrim Care Companion CNS Disord2013151PCC.12101443
   Google Scholar
• PrabhuswamyMSrinathSGirimajiSSeshadriSRisperidone-induced priapism in a 12-year-old boy with schizophreniaJ Child Adolesc Psychopharmacol200717453954017822349
   PubMed Web of Science ®Google Scholar
• HusárMZerhauPPriapism in childhood-case report of 14-year-old boyRozhl Chir200685732933017044274
   PubMedGoogle Scholar
• BrichartNDelavierreDPeneauMIbrahimHMallekAPriapism associated with antipsychotic medications: a series of four patientsProg Urol2008181066967318971111
   PubMed Web of Science ®Google Scholar
• ReevesRRKimbleRProlonged erections associated with ziprasidone treatment: a case reportJ Clin Psychiatry2003641979812590634
   PubMed Web of Science ®Google Scholar
• MitchellJEPopkinMKAntipsychotic drug therapy and sexual dysfunction in menAm J Psychiatry198213956336376122381
   PubMed Web of Science ®Google Scholar
• SongerDABarclayJCOlanzapine-induced priapismAm J Psychiatry2001158122087208811729037
   PubMed Web of Science ®Google Scholar
• ShahSKA comparative study of sexual dysfunction in schizophrenia patients taking aripiprazole versus risperidoneKathmandu Univ Med J20131142121125
   PubMedGoogle Scholar
• AndersohnFSchmedtNWeinmannSWillichSNGarbeEPriapism associated with antipsychotics: role of alpha1 adrenoceptor affinityJ Clin Psychopharmacol2010301687120075651
   PubMed Web of Science ®Google Scholar
• OgłodekESzotaAJustMMośDAraszkiewiczAThe role of the neuroendocrine and immune systems in the pathogenesis of depressionPharmacol Rep201466577678125149980
   PubMed Web of Science ®Google Scholar